Molecular Partners AG - ADR

NASDAQ:MOLN   11:22:31 AM EDT
3.76
+0.05 (+1.35%)
: $3.72 -0.04 (-1.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Molecular Partners AG - ADR Stock, NASDAQ:MOLN

Wagistrasse 14, Schlieren, Schlieren, Zurich 8952
Switzerland
Phone: +41.44.755.77.00
Number of Employees: 174

Description

Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274, and Clinical Trials. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas PlÃ?Â?ckthun, and Michael Tobias Stumpp on November 22, 2004 and is headquartered in Schlieren, Switzerland.